ResearchLessons learned on access, equity, and collaboration between public hospital Infectious Diseases leadership and the Health Department during the 2025 Legionnaires’disease outbreak response in New York City
ResearchP-2072. Sociodemographics and Viral Load Outcomes of People Newly Diagnosed with HIV or Returning to HIV Care Receiving RapidTx Cards at NYC Health+Hospitals/Bellevue
ResearchP-218. Examining CD4, Viral Load and STI Co-Infection as Predictors of Severe Mpox Outcomes Among a Cohort of People with HIV in New York City
ResearchP-308. Understanding Recruitment into a Long-acting Injectable Pre-exposure Prophylaxis Trial: Lessons Learned to Enhance Equity and Optimize Engagement of Underserved Groups
ResearchP-2058. Healthcare Utilization Before and After Enrollment in the New York City Health + Hospitals/Bellevue Health Equity Action Team, 2022-2024
ResearchPatterns and Gaps in Mpox Vaccination at NYC Health + Hospitals, a Large Urban Safety Net Health System in New York City, 2022-2025
ResearchP-735. Healthcare Experiences of Sexual Minority Men with Severe Mpox During the New York City Outbreak: Lessons from In-Depth Interviews
Sep 12, 2026PerspectiveHonoring the Legacy of the HIV EpidemicWritten by 1 Roon author Via The New England Journal of Medicine
ResearchP-1317. Beyond Clinical Factors: Examining the Association between Socioeconomic Status and Severe Mpox Disease in NYC
ResearchHealth Insurance Status and Severe Mpox Disease Outcomes Among Sexual Minority Men in NYC: A Retrospective Cohort Study
ResearchA Just Appraisal: Co-creating a New Health Equity Framework with Learners through Journal Club to Evaluate the Literature
Apr 30, 2026Journal ArticleClinical Outcomes of Mpox Disease in Patients Treated With Tecovirimat.Written by 2 Roon authors & 27 others Via Clinical Infectious Diseases
ResearchThe Role of the Multidisciplinary HIV Care Center in Mitigating Social Isolation Among Patients with HIV During the Early COVID-19 Pandemic
ResearchSevere Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City